Management of intracranial melanoma metastasis with radiosurgery: a case report and literature review

Abstract

Malignant melanoma is a devastating disease with a 5-year survival rate of approximately 20%. At the time of diagnosis, approximately 4% of patients had metastatic disease and between 5% and 20% had brain metastases. Most patients with intracranial metastatic melanoma have been treated with holocranial radiotherapy. Stereotactic radiosurgery is non-inferior to holocranial radiotherapy and has the advantage of preserving cognitive functions. This manuscript aims to show a case report of multiple melanoma metastases treated with stereotactic radiosurgery.

Keywords

• Melanoma. Metastasis. Central nervous system. Radiosurgery.